PTH and chronic kidney disease: This threshold of 30 ng/mL was used for several studies in which the value of plasma PTH was lowered for plasma values of vitamin D > 30 ng/mL in a population of osteoporotic patients being treated with bisphosphonates, a medication that lowers the plasma concentration of PTH, and not in patients with CKD [8–10].